Local pharma sector to benefit from EU connection

Local pharma sector to benefit from EU connection

Despite lower-than-expected growth, Vietnam’s pharmaceutical market performed better than other global markets in the past 12 months. Magdalena Krakowiak, chairwoman of the International Quality Medicines’ Generic and Biosimilar Sector Committee (IQMED) at the European Chamber of Commerce in Vietnam, writes about 2020 results and future prospects thanks to the EU-Vietnam Free Trade Agreement.
The prescription for 2021 – to invest in high quality and give back to society

The prescription for 2021 – to invest in high quality and give back to society

In 2020, Vietnam’s pharmaceutical market is estimated to have grown by around 4 per cent compared to the previous year, according to healthcare data multinational IQVIA. The market is expected to continue growing significantly in terms of both capacity and value thanks to the country’s population size of nearly 100 million people, improved access to healthcare, and the government’s efforts to promote universal health insurance.